Foxd1 is a mediator and indicator of the cell reprogramming process

Nature Communications

Volumn 5, Issue , 2014, Pages

  Koga, Makito ^a,b   Matsuda, Mitsuhiro ^a,b   Kawamura, Teruhisa ^b,c   Sogo, Takahiro ^b,d   Shigeno, Asako ^b,c   Nishida, Eisuke ^b,e   Ebisuya, Miki ^a,b,e  

^a RIKEN Center for Biosystems Dynamics Research   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c RITSUMEIKAN UNIVERSITY   (Japan)

^d NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FOXD1 PROTEIN, MOUSE; FOXO1 PROTEIN, MOUSE;

ANIMAL; C57BL MOUSE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HEK293 CELL LINE; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; NUCLEAR REPROGRAMMING;

ANIMALS; CELLULAR REPROGRAMMING; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; MICE, INBRED C57BL; MICE, INBRED ICR;

EID: 84893833250     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4197     Document Type: Article

References (42)

1. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006). (Pubitemid 44233629)
2. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007). (Pubitemid 350138099)
3. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
4. Park, I. H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141-146 (2008).
5. Lowry, W. E. et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl Acad. Sci. USA 105, 2883-2888 (2008). (Pubitemid 351723638)
6. Maherali, N. et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55-70 (2007).
7. Wernig, M. et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318-324 (2007). (Pubitemid 47080337)
8. Mikkelsen, T. S. et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49-55 (2008). (Pubitemid 351931978)
9. Sridharan, R. et al. Role of the murine reprogramming factors in the induction of pluripotency. Cell 136, 364-377 (2009).
10. Onder, T. T. et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature 483, 598-602 (2012).
11. Liang, G., He, J. & Zhang, Y. Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming. Nat. Cell Biol. 14, 457-466 (2012).
12. Koche, R. P. et al. Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell 8, 96-105 (2011).
13. Samavarchi-Tehrani, P. et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 7, 64-77 (2010).
14. Meissner, A., Wernig, M. & Jaenisch, R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 25, 1177-1181 (2007). (Pubitemid 47538112)
15. Smith, Z. D., Nachman, I., Regev, A. & Meissner, A. Dynamic single-cell imaging of direct reprogramming reveals an early specifying event. Nat. Biotechnol. 28, 521-526 (2010).
16. Hanna, J. et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462, 595-601 (2009).
17. Buganim, Y. et al. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 150, 1209-1222 (2012).
18. Kitamura, T. et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp. Hematol. 31, 1007-1014 (2003). (Pubitemid 37329742)
19. Chambers, I. et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655 (2003). (Pubitemid 36694189)
20. Mitsui, K. et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642 (2003). (Pubitemid 36694188)
21. Nichols, J. et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391 (1998). (Pubitemid 28507326)
22. Kel, A. E. et al. MATCH: a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res. 31, 3576-3579 (2003). (Pubitemid 37442201)
23. Matys, V. et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 34, D108-D110 (2006).
24. Suzuki, Y., Yamashita, R., Sugano, S. & Nakai, K. DBTSS, DataBase of Transcriptional Start Sites: progress report 2004. Nucleic Acids Res. 32, D78-D81 (2004). (Pubitemid 38081608)
25. Hatini, V., Huh, S. O., Herzlinger, D., Soares, V. C. & Lai, E. Essential role of stromal mesenchyme in kidney morphogenesis revealed by targeted disruption of Winged Helix transcription factor BF-2. Genes Dev. 10, 1467-1478 (1996). (Pubitemid 26260704)
26. Levinson, R. S. et al. Foxd1-dependent signals control cellularity in the renal capsule, a structure required for normal renal development. Development 132, 529-539 (2005). (Pubitemid 40277693)
27. Humphreys, B. D. et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 85-97 (2010).
28. Carreres, M. I. et al. Transcription factor Foxd1 is required for the specification of the temporal retina in mammals. J. Neurosci. 31, 5673-5681 (2011).
29. Carter, M. E. & Brunet, A. FOXO transcription factors. Curr. Biol. 17, R113-R114 (2007). (Pubitemid 46241884)
30. Kloet, D. E. & Burgering, B. M. The PKB/FOXO switch in aging and cancer. Biochim. Biophys. Acta 1813, 1926-1937 (2011).
31. Zhang, X. et al. FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Nat. Cell Biol. 13, 1092-1099 (2011).
32. Yu, Y. et al. Stimulation of somatic cell reprogramming by Eras-Akt-Foxo1 signaling axis. Stem Cells 32, 349-363 (2013).
33. Wernig, M., Meissner, A., Cassady, J. P. & Jaenisch, R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2, 10-12 (2008).
34. Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101-106 (2008).
35. Kim, J. H. et al. Regulation of adipose tissue stromal cells behaviors by endogenic Oct4 expression control. PLoS One 4, e7166 (2009).
36. Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317 (2007). (Pubitemid 47080336)
37. Kim, J., Chu, J., Shen, X., Wang, J. & Orkin, S. H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132, 1049-1061 (2008). (Pubitemid 351381745)
38. Niakan, K. K. et al. Novel role for the orphan nuclear receptor Dax1 in embryogenesis, different from steroidogenesis. Mol. Genet. Metab. 88, 261-271 (2006). (Pubitemid 43963432)
39. Khalfallah, O., Rouleau, M., Barbry, P., Bardoni, B. & Lalli, E. Dax-1 knockdown in mouse embryonic stem cells induces loss of pluripotency and multilineage differentiation. Stem Cells 27, 1529-1537 (2009).
40. Kawamoto, S. et al. A novel reporter mouse strain that expresses enhanced green fluorescent protein upon Cre-mediated recombination. FEBS Lett. 470, 263-268 (2000). (Pubitemid 30169275)
41. Yamanaka, S. Elite and stochastic models for induced pluripotent stem cell generation. Nature 460, 49-52 (2009).
42. Kawamura, T. et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460, 1140-1144 (2009).